Ausgabe 1/2021
Inhalt (36 Artikel)
Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn
Ioannis Koutsavlis
Is there a gender effect in polycythemia vera?
Francesca Palandri, Barbara Mora, Naseema Gangat, Lucia Catani
An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia
Sylvie Stacy, Sujit Sheth, Brandon Coleman, Wendy Cerenzia
Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection
Abdulrahman A. Algassim, Assem A. Elghazaly, Abdulrahman S. Alnahdi, Owais M. Mohammed-Rahim, Abdulaziz G. Alanazi, Nawaf A. Aldhuwayhi, Mashael M. Alanazi, Mohammed F. Almutairi, Ibrahim M. Aldeailej, Najeeb A. Kamli, Mahmoud D. Aljurf
Characteristics of coagulation alteration in patients with COVID-19
Hong-chun Luo, Cheng-yan You, Si-wei Lu, Yue-qiang Fu
Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine
Yang Lan, Lixian Chang, Meihui Yi, Yuli Cai, Jing Feng, Yuanyuan Ren, Chao Liu, Xiaoyan Chen, Shuchun Wang, Ye Guo, Aoli Zhang, Lipeng Liu, Jingliao Zhang, Xiaofan Zhu
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia
Filipe Martins, Michael Kruszewski, Ilaria Scarpelli, Jacqueline Schoumans, Olivier Spertini, Michael Lübbert, Sabine Blum
Antibiotic use during cytarabine consolidation in acute myeloid leukemia
Colin A. Vale, Pamela C. Egan, Randall Ingham, Dimitrios Farmakiotis, John L. Reagan
Efficacy and safety profile of generic imatinib in patients with newly diagnosed chronic myeloid leukemia-chronic phase: sharing experience of a hemato-oncology center from eastern India
Abhijit Phukan, Prakas Kumar Mandal, Tuphan K. Dolai
Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm
David C. A. Molitor, Peter Boor, Andreas Buness, Rebekka K. Schneider, Lino L. Teichmann, Ruth-Miriam Körber, Gabor L. Horvath, Steffen Koschmieder, Ines Gütgemann
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis
Benedetta Rambaldi, Elisa Diral, Samantha Donsante, Noemi Di Marzo, Federica Mottadelli, Lucia Cardinale, Erica Dander, Giuseppe Isimbaldi, Pietro Pioltelli, Andrea Biondi, Mara Riminucci, Giovanna D’Amico, Elena Maria Elli, Alice Pievani, Marta Serafini
Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019
Konnie Hebeda, Ludmila Boudova, Christine Beham-Schmid, Attilio Orazi, Hans-Michael Kvasnicka, Umberto Gianelli, Alexandar Tzankov
Low-dose ruxolitinib shows effective in treating myelofibrosis
Yunfan Yang, Hongmei Luo, Yuhuan Zheng, Zhongqing Zou, Ting Niu, Yongqian Jia, Huanling Zhu, Ting Liu, Yu Wu, Hong Chang, Jie Ji, Jian Li, Ling Pan
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes
William J. Archibald, Kari G. Rabe, Brian F. Kabat, Joerg Herrmann, Wei Ding, Neil E. Kay, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Yucai Wang, Asher A. Chanan-Khan, Susan M. Schwager, Amber B. Koehler, Amie L. Fonder, Susan L. Slager, Tait D. Shanafelt, Timothy G. Call, Sameer A. Parikh
Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry
Shigeo Fuji, Shuhei Kida, Kayo Nakata, Toshitaka Morishima, Isao Miyashiro, Jun Ishikawa
Correction to: Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry
Shigeo Fuji, Shuhei Kida, Kayo Nakata, Toshitaka Morishima, Isao Miyashiro, Jun Ishikawa
Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamide
Jiao-Yu Zhao, Si-Ning Liu, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Yu-Hong Chen, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo
Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
Catharina Van Elssen, Gwendolyn van Gorkom, Christine Voorter, Peter von dem Borne, Ellen Meijer, Lotte Wieten, Gerard Bos
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
Jae-Cheol Jo, Jin-Seok Kim, Je-Hwan Lee, Jung-Hee Lee, Seong Nam Im, Sang-Min Lee, Sung-Soo Yoon, In-Ho Kim, Seong Hwa Bae, Yoo Jin Lee, Yunsuk Choi, Won-Sik Lee
Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study
Yasuo Mori, Kensuke Sasaki, Yoshikiyo Ito, Takuro Kuriyama, Toshiyuki Ueno, Masanori Kadowaki, Takatoshi Aoki, Takeshi Sugio, Goichi Yoshimoto, Koji Kato, Takahiro Maeda, Koji Nagafuji, Koichi Akashi, Toshihiro Miyamoto
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
Claire Seydoux, Michael Medinger, Sabine Gerull, Joerg Halter, Dominik Heim, Yves Chalandon, Stavroula Masouridi Levrat, Urs Schanz, Gayathri Nair, Marc Ansari, Patrick Simon, Jakob R. Passweg, Nathan Cantoni
Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia
Yasushi Onishi, Takehiko Mori, Hirohito Yamazaki, Katsuto Takenaka, Hiroki Yamaguchi, Naoki Shingai, Yukiyasu Ozawa, Hiroatsu Iida, Shuichi Ota, Naoyuki Uchida, Toshihiro Miyamoto, Yuta Katayama, Jun Kato, Satoshi Yoshioka, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta
Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study
Andry Van de Louw, Kathleen Twomey, Nicholas Habecker, Kevin Rakszawski
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Boris Böll, Enrico Schalk, Dieter Buchheidt, Justin Hasenkamp, Michael Kiehl, Til Ramon Kiderlen, Matthias Kochanek, Michael Koldehoff, Philippe Kostrewa, Annika Y. Claßen, Sibylle C. Mellinghoff, Bernd Metzner, Olaf Penack, Markus Ruhnke, Maria J. G. T. Vehreschild, Florian Weissinger, Hans-Heinrich Wolf, Meinolf Karthaus, Marcus Hentrich
Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study
Loes L. Cornelissen, Aukje L. Kreuger, Camila Caram-Deelder, Rutger A. Middelburg, Jean Louis H. Kerkhoffs, Peter A. von dem Borne, Erik A. M. Beckers, Karen M. K. de Vooght, Jürgen Kuball, J. J. Zwaginga, Johanna G. van der Bom
An atypical chronic neutrophilic leukemia patient harboring ASXL1 and NRAS mutations associated with monoclonal plasma cell dyscrasia presenting as hemopericardium
Qiaoyan Han, Lan Tao, Xin Jiang, Haoyue Chen, Chunhua Liu, Miao Sun
Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation
Annalen Bleckmann, Sascha Dierks, Hans-Ulrich Schildhaus, Niels Hellige, Ulrike Bacher, Lorenz Trümper, Gerald Wulf
Congenital dyserythropoietic anemia type IV with high fetal hemoglobin caused by heterozygous KLF1 p.Glu325Lys: first report in an Indian infant
Manu Jamwal, Anu Aggarwal, Prashant Sharma, Deepak Bansal, Reena Das
Fluctuating plasmacytosis in an immunocompetent woman leading a diagnosis of plasmablastic lymphoma
Camille Debord, Jessie Bourcier, François Subiger, François Leclair, Cyrille Touzeau, Thomas Gastinne, Anne Moreau, Olivier Theisen, Catherine Godon, Nelly Robillard, Yannick Le Bris, Marie C Béné, Soraya Wuillème
Long-term treatment response to PD-1 blockade therapy in a patient with DLBCL relapsed after anti-CD19 chimeric antigen receptor T cell treatment
Lu Zhang, Wei Zhang, Daobin Zhou
Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia
Ozlem Ozbagcivan, Sevgi Akarsu, Ecem Canturk Nazli, Banu Lebe, Emel Fetil
A rare case of donor-derived promyelocytic sarcoma in a kidney transplant recipient
Jiaying Liu, Lijing Shen, Honghui Huang, Xiao Gao, Shan Mou, Liang Ying, Tingyu Yin
Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma
Martin Kaiser, Meral Beksaç, Nina Gulbrandsen, Fredrik Schjesvold, Roman Hájek, Philippe Moreau, Felipe de Arriba de la Fuente, María-Victoria Mateos, Sharon West, Andrew Spencer, S. Vincent Rajkumar, Kaveri Suryanarayan, Michael Czorniak, Cong Li, Zhaoyang Teng, Richard Labotka, Meletios A. Dimopoulos
Correction to: The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of pet-guided treatments
Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, Alessandro Re, Chiara Pagani, Alessandra Tucci, Barbara Botto, Umberto Vitolo, Anna Lia Molinari, Benedetta Puccini, Alessandro Pulsoni, Armando Santoro, Monica Tani, Luca Nassi, Erika Meli, Vincenzo Pavone, Maurizio Bonfichi, Andrea Evangelista, Daniela Gioia, Alessandro Levis, Pierluigi Zinzani
Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia
Ke Wan, Yafei Yin, Zimian Luo, Jianzhao Cheng
Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia—report from a single center in China
Jing Ruan, Wei Zuo, Miao Chen, Chen Yang, Bing Han